ISSN:
Journal Home
Journal Guideline
Molecular Cancer Therapeutics Q1 Unclaimed
American Association for Cancer Research Inc.
United States
Molecular Cancer Therapeutics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 173. It has a price of 3000 €. It has an SJR impact factor of 2,717 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,717.
Molecular Cancer Therapeutics focuses its scope in these topics and keywords: inhibitor, potent, cancer, resistance, protein, cells, vitro, inhibition, activity, receptor, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
Categories:
Cancer Research (Q1)
Oncology (Q1)
Price
3000 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
2,717
SJR Impact factor173
H Index244
Total Docs (Last Year)747
Total Docs (3 years)10829
Total Refs4623
Total Cites (3 years)726
Citable Docs (3 years)5,27
Cites/Doc (2 years)44,38
Ref/DocOther journals with similar parameters
JAMA oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
CA - A Cancer Journal for Clinicians Q1
Cancer Discovery Q1
Compare this journals
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments